Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 80,951 | 357,399 | 734,577 | 185,925 | 703,971 |
| Cost of Goods | 34,086 | 181,765 | 434,593 | 271,077 | 15,204 |
| Gross Profit | 46,865 | 175,634 | 299,984 | -85,152 | 688,767 |
| Operating Expenses | 359,719 | 420,278 | 427,766 | 397,885 | 479,679 |
| Operating Income | -312,768 | -243,879 | -127,189 | -482,960 | 209,292 |
| Interest Expense | 4,316 | 4,601 | 4,169 | 6,234 | 4,876 |
| Other Income | 24,362 | 63,971 | -34,783 | -19,873 | 1,654 |
| Pre-tax Income | -292,722 | -184,509 | -166,141 | -509,067 | 206,070 |
| Income Tax | 1,183 | -2,260 | 2,472 | 1,418 | 2,662 |
| Net Income Continuous | -293,905 | -182,249 | -168,613 | -510,485 | 203,408 |
| Net Income | $-293,905 | $-182,249 | $-168,613 | $-510,485 | $203,408 |
| EPS Basic Total Ops | -3.41 | -2.40 | -2.15 | -6.53 | 2.66 |
| EPS Basic Continuous Ops | -3.41 | -2.39 | -2.15 | -6.53 | 2.66 |
| EPS Diluted Total Ops | -3.41 | -2.30 | -2.15 | -6.53 | 2.56 |
| EPS Diluted Continuous Ops | -3.41 | -2.25 | -2.15 | -6.53 | 2.52 |
| EBITDA(a) | $-303,725 | $-236,657 | $-118,842 | $-476,240 | $216,057 |